Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

A call to reform the taxonomy of human disease

Abstract

A coordinated effort to incorporate advances in the understanding of the molecular and genomic variations in common diseases, such as hypertension, into their diagnosis and treatment could transform drug development and medicine.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kola, I. and Landis, J. Can the pharmaceutical industry reduce attrition rates? Nature Rev. Drug Discov. 3, 711–715 (2004).

    Article  CAS  Google Scholar 

  2. Arrowsmith, J. Phase II failures: 2008–2010. Nature Rev. Drug Discov. 10, 328–329 (2011).

    Article  CAS  Google Scholar 

  3. Billings, L. K. & Florez, J. C. The genetics of type 2 diabetes: what have we learned from GWAS? Ann. NY Acad. Sci. 1212, 59–77 (2010).

    Article  CAS  PubMed  Google Scholar 

  4. Hyman, S. E. Can neuroscience be integrated into the DSM-V? Nature Rev. Neurosci. 8, 725–732 (2007).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kola, I., Bell, J. A call to reform the taxonomy of human disease. Nat Rev Drug Discov 10, 641–642 (2011). https://doi.org/10.1038/nrd3534

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd3534

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research